Defearisox Film-Coated

Name: Defearisox Film-Coated in Chronic Iron Overload Due to Transfusion-dependant Anemias
Creator: Floatz
License: https://terminal.floatz.ai/terms

Chronic Iron Overload Due to Transfusion-dependant Anemias

Novartis PharmaceuticalsPhase 2Dormant

57/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 42/ 100
Competitive Position: 95/ 100

Competitive context

0 Active assets in the Chronic Iron Overload Due to Transfusion-dependant Anemias cohort.

Asset / Sponsor	Phase	Rating
Deferasirox Novartis Pharmaceuticals	Phase 4	A
Deferiprone Ain Shams University	Phase 3	BB
Deferasirox Novartis Pharmaceuticals	Phase 2	B
Deferitazole Shire	Phase 2	B
DESFERRIOXAMINE B Novartis Pharmaceuticals	Phase 2	B
DESFERRIOXAMINE B Ain Shams University	Phase 2	B
10-(1-methylpiperidin-4-ylidene)-5,10-dihydro-4H-benzo[5,6]cyclohepta[1,2-b]thiophen-4-one Horus University		D
Ferriprox Ain Shams University	N/A	D

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →